is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Countries globally are expected to maintain a test volume exceeding 500,000 subjects per day, with an increasing amount using POCT technology. The volume of testing is expected to be maintained to monitor the outbreak and inform preventative measures.
Investments and innovation in point-of-care diagnostics for infectious diseases and population surveillance will continue. Free drive-through and walk-through testing will lead to an emergence of alternate testing sites, such as pharmacies or ports of entry. Even though flu testing at pharmacies has become common, 2020 will usher in an era where pharmacies offer an unprecedented level of convenience to patients.
Clinical laboratory sector has proven to be one of the most fundamental divisions in today’s value chain of the healthcare industry. It is undeniable that the significance of clinical laboratory sector has relatively grown in KSA over the recent years. Laboratory tests have not only aid the identification of disease by determining the existence, absence as well as its extensiveness, but also to further monitor the potency of treatment
UAE has been demonstrating vigorous economic growth over the last two decades,from medical tourism to government initiative in developing the infrastructure particularly in healthcare as well as raising awareness of a disease that may beinfectious. Clinical laboratory market has generally managed to maintain an elevated position in the UAE
According to data from “World Population Prospects: the 2017 Revision”, the number of older persons — those aged 60 years or over — is expected to more than double by 2050 and to more than triple by 2100, rising from 962 million globally in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100. Globally, population aged 60 or over is growing faster than all younger age groups
As the world’s demographics change, healthcare systems around the world will face significant challenges to meet the needs of an aging population. In this context, the clinical laboratory can play an important role by defining proper reference ranges, identifying disease processes early, and aiding in the treatment process.
The global clinical laboratory services market is estimated at US $205.56 billion in 2016 and is expected to reach US $333.45 billion by 2023, growing at a CAGR of 7.1% from 2016 to 2023, according to a report by WiseGuyReports.com
From the past few years, the global market for clinical laboratory services is expected to grow from US $210,341 million in 2017 to US $274,450 million by 2023. Under the scope of the study by WideGuyReports.com, the global market for clinical laboratory services is segmented into four major regions, namely, the Americas, APAC, Europe, and the Middle East and Africa. These regions are estimated to hold approximately 98.92% of the market, collectively. Moreover, it is estimated that the Americas held the largest share (by revenue) in 2017
• Discuss leadership in the clinical laboratory
• Review responsibilities of the Laboratory Director to oversee the laboratory in providing the necessarytests and quality to ensure effective patient care
• Outline common pitfalls in fulfilling Laboratory Director role